At Dakshin Health Summit, dermatology experts warned India is facing an epidemic of steroid misuse in skin treatments, with rampant OTC sales and cosmetic abuse fuelling serious and lasting health damage. They urged stronger regulation, patient awareness, and tighter controls to curb misuse, cautioning rise of a new fungal strain, Trichophyton indotineae, could reverse decades of medical progress.